Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Conmed Q3 Adj. EPS $1.08 Beats $1.05 Estimate, Sales $337.900M Beat $334.760M Estimate

Author: Benzinga Newsdesk | November 05, 2025 04:28pm
Conmed (NYSE:CNMD) reported quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $1.05 by 2.66 percent. This is a 2.86 percent increase over earnings of $1.05 per share from the same period last year. The company reported quarterly sales of $337.900 million which beat the analyst consensus estimate of $334.760 million by 0.94 percent. This is a 6.69 percent increase over sales of $316.701 million the same period last year.

Posted In: CNMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist